Rhumbline Advisers Acquires 41,891 Shares of Sotera Health Company $SHC

Rhumbline Advisers grew its holdings in Sotera Health Company (NASDAQ:SHC) by 10.4% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 444,640 shares of the company’s stock after purchasing an additional 41,891 shares during the quarter. Rhumbline Advisers owned approximately 0.16% of Sotera Health worth $6,994,000 at the end of the most recent reporting period.

Several other hedge funds have also recently modified their holdings of SHC. Sculptor Capital LP increased its holdings in Sotera Health by 27.2% during the second quarter. Sculptor Capital LP now owns 11,500,000 shares of the company’s stock valued at $127,880,000 after buying an additional 2,462,489 shares during the period. MIG Capital LLC boosted its position in Sotera Health by 3.3% during the 2nd quarter. MIG Capital LLC now owns 5,282,339 shares of the company’s stock valued at $58,740,000 after acquiring an additional 168,388 shares in the last quarter. Two Seas Capital LP increased its holdings in shares of Sotera Health by 21.1% in the 2nd quarter. Two Seas Capital LP now owns 4,020,867 shares of the company’s stock valued at $44,712,000 after acquiring an additional 699,731 shares during the period. Geode Capital Management LLC raised its position in shares of Sotera Health by 1.9% in the 2nd quarter. Geode Capital Management LLC now owns 2,913,391 shares of the company’s stock worth $32,402,000 after acquiring an additional 53,654 shares in the last quarter. Finally, Bank of America Corp DE lifted its stake in shares of Sotera Health by 40.2% during the 2nd quarter. Bank of America Corp DE now owns 916,156 shares of the company’s stock worth $10,188,000 after purchasing an additional 262,772 shares during the last quarter. Hedge funds and other institutional investors own 91.03% of the company’s stock.

Analyst Ratings Changes

Several research firms have issued reports on SHC. BMO Capital Markets initiated coverage on Sotera Health in a research note on Thursday, November 13th. They issued an “outperform” rating and a $19.00 target price on the stock. Piper Sandler raised shares of Sotera Health from a “neutral” rating to an “overweight” rating and lifted their price objective for the stock from $17.00 to $24.00 in a research report on Friday, January 9th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Sotera Health in a research note on Monday, December 29th. JPMorgan Chase & Co. raised their target price on shares of Sotera Health from $14.00 to $16.00 and gave the company a “neutral” rating in a research note on Wednesday, November 5th. Finally, Royal Bank Of Canada started coverage on shares of Sotera Health in a report on Thursday, January 8th. They issued an “outperform” rating and a $24.00 price target on the stock. Seven research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $20.00.

Insider Activity

In other news, Director Gtcr Investment Xi Llc sold 6,480,000 shares of the business’s stock in a transaction on Wednesday, December 3rd. The shares were sold at an average price of $16.33, for a total transaction of $105,818,400.00. Following the sale, the director directly owned 22,735,301 shares of the company’s stock, valued at $371,267,465.33. The trade was a 22.18% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Michael B. Jr. Petras sold 434,104 shares of the firm’s stock in a transaction on Monday, December 8th. The stock was sold at an average price of $16.45, for a total value of $7,141,010.80. The disclosure for this sale is available in the SEC filing. Insiders have sold 17,384,104 shares of company stock valued at $284,024,511 over the last ninety days. 55.12% of the stock is currently owned by insiders.

Sotera Health Stock Up 0.5%

SHC stock opened at $17.49 on Monday. The stock has a market capitalization of $4.97 billion, a PE ratio of 92.06 and a beta of 1.82. Sotera Health Company has a 52 week low of $9.53 and a 52 week high of $19.85. The company has a quick ratio of 2.18, a current ratio of 2.38 and a debt-to-equity ratio of 4.04. The firm has a 50 day moving average of $17.97 and a 200 day moving average of $16.77.

Sotera Health Company Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.